SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tony van Werkhooven who wrote (641)3/20/1999 6:41:00 PM
From: David Israel-Rosen  Read Replies (2) of 1386
 
Setting the record Straight: BE SMART and BUY BUY BUY

Pars business is sound. It has enough cash as well ample access to Capital.

The Price action of the stock is not supported by REALITY. The price is pushed down by LACK of BUYERS and PANICK of people who are getting out of the stock at the BOTTOM.

Within 100 days we will have a HU211 partner additional capital and a stock in the $2-3 dollar range which leads me and you to the same conclusion that it is time to BUY.

P.S. I heard that some of CC 1500 shares had been converted to equity

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext